GECAMed, First Luxembourgish Software to Obtain IHE Conformity

GECAMedGECAMed, the medical office management software, developed by the Luxembourg Institute of Science and Technology (LIST) and widely used by Luxembourgish healthcare professionals, has successfully passed IHE profile conformance testing. The interoperability of GECAMed with other solutions available for professionals in the healthcare sector is therefore clearly demonstrated, a first for a Luxembourgish product and moreover for an open source solution.

At the end of April 2015, researchers from the Luxembourg Institute of Science and Technology (LIST) participated in the IHE-Europe Connectathon, an annual connectivity test marathon organised in Luxembourg by IHE-Europe in partnership with the national eSanté Agency. IHE-Europe is the European section of Integrating the Healthcare Enterprise (IHE), an international initiative bringing together professionals from the healthcare and industry sectors, including LIST, to improve information exchange between software systems in this field. The IHE initiative defines integration profiles in order to achieve a high interoperability rate between the systems available to healthcare professionals. The validity of their implementation is tested every year in the context of the Connectathon, where industry professionals meet and connect their applications by using the IHE profiles for designing virtual hospital information systems within a variety of fields, including radiology, cardiology, patient-devices, IT infrastructure, etc.

For the latter, LIST submitted its GECAMed medical office management software for an intensive week of conformance testing, which it successfully passed. GECAMed has thus become not only the first system in Luxembourg to be certified but also the first open-source medical office management system to pass this test with flying colours. This event marks real recognition for the software, since the proven IHE conformity certifies that GECAMed meets all of the strict interoperability criteria regarding security and data sharing at a high international standard.

Towards the integration of GECAMed in the national eHealth platform
GECAMed is a secure open source platform developed by LIST researchers in partnership with doctors in order to manage and use medical data. First launched in 2005 with the support of the Ministry of Health, it has since been constantly adapted and improved in order to meet the needs of professionals in the healthcare sector.

Researchers are currently working towards its technical integration into the national eHealth platform as part of the GECAMed eSanté project co-funded by the eHealth Agency and IDO IN. They therefore designed a new version which integrates patient data from shared medical records (Dossier de Soins Partagé - DSP) with GECAMed data in a user-friendly and transparent way, while complying with the data security and protection guidelines established by the eHealth Agency. Thanks to developments achieved within this project, healthcare professionals will no longer be forced to use the web interface of the eHealth platform. They will have direct access to all documents from their own patient record into which they will also be able to directly integrate documents from the DSP. Local documents and documents from the eHealth platform will therefore be able to be managed very quickly and easily with GECAMed.

For further information, please visit:
http://www.gecamed.lu

About Luxembourg Institute of Science and Technology (LIST)
The Luxembourg Institute of Science and Technology (LIST) is an RTO (Research and Technology Organisation) active in the fields of materials, environment, and IT. Our mission is twofold:

  • contributing to Luxembourg's reputation through our participation in several targeted research areas among the best RTOs,
  • significantly participating in the country's socio-economic development.

To this end, we participate in several national and European competitive research programmes. We disseminate our results through scientific publications in internationally renowned journals, results that we protect by filing patents and that we transfer to key players in the private or public sector.

Thanks to our activities in applied research and technology transfer, we support companies in their innovation projects. The objective is to enable them to enhance their competitiveness in regional, national, and international markets.

Furthermore, we also contribute to the setting up of new companies in Luxembourg through the development of innovative technology and expertise.

Lastly, we offer our scientific support to national policy making in our research areas in order to forecast and support societal changes.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...